acamprosate vs rasagiline
Side-by-side comparison of acamprosate and rasagiline Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Campral
Azilect
Acamprosate is a medicine that can help you stay away from alcohol if you are alcohol-dependent and have already stopped drinking. It should be used with counseling and support.
Rasagiline (Azilect) is a medicine used to treat Parkinson's disease. It helps to improve motor control and reduce symptoms like tremors and stiffness.
Acamprosate helps people who are alcohol-dependent to not drink alcohol. You must have already stopped drinking before you start taking acamprosate. This medicine works best when it is part of a complete treatment plan that includes counseling and support.
Rasagiline is used to treat Parkinson's disease. Parkinson's disease is a brain disorder that affects movement. This medicine can be used alone or with other Parkinson's medicines to help control your symptoms.
Acamprosate is similar to a natural substance in your brain. It is thought to work by helping to restore the normal balance of brain activity that is changed by long-term alcohol use. This can reduce your craving for alcohol.
Rasagiline belongs to a class of drugs called MAO-B inhibitors. It works by increasing the levels of certain chemicals in the brain. These chemicals help to control movement and reduce Parkinson's symptoms.
- • Accidental injury
- • Weakness
- • Pain
- • Loss of appetite
- • Diarrhea
- • Flu-like symptoms
- • Joint pain
- • Depression
- • Indigestion
- • Swelling in the arms or legs
- Low blood pressure 14
- Weakness 13
- Condition worsened 13
- Using the medicine for something it is not approved for 13
- Sudden kidney damage 12
- Falling 343
- Seeing or hearing things that are not there 326
- Uncontrolled movements 276
- Medicine not working 272
- Parkinson's disease 216
Acamprosate may increase the risk of suicidal thoughts or actions. Your doctor should watch you for depression or suicidal thoughts. Tell your doctor right away if you have any new or worsening symptoms of depression or suicidal thoughts.
Rasagiline can cause high blood pressure. It can also cause serotonin syndrome, a serious condition, especially when taken with antidepressants. You may fall asleep suddenly or feel very drowsy. Rasagiline can also cause or worsen uncontrolled movements, hallucinations, and compulsive behaviors. Tell your doctor if you experience any of these side effects.
Acamprosate may harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if acamprosate passes into breast milk. Talk to your doctor if you are breastfeeding.
It is not known if rasagiline can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if rasagiline passes into breast milk, so talk to your doctor if you are breastfeeding.
Also Compare — Nearby Drugs
Compare rasagiline with
How to Read This acamprosate vs rasagiline Comparison
acamprosate is classified in the GABA Analog (Alcohol Dependence) drug class, while rasagiline sits within the MAO-B Inhibitor class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, acamprosate has 65 submissions while rasagiline has 1,433. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between acamprosate and rasagiline — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.